Deregulated Fc{gamma} receptor expression in patients with CIDP

Conclusions:
The FcR regulatory system is disturbed in patients with CIDP. Balancing activating vs inhibitory FcR expression might provide a clinical benefit for patients with CIDP.

Source: Neurology Neuroimmunology and Neuroinflammation - August 20, 2015 Category: Neurology Authors: Quast, I., Cueni, F., Nimmerjahn, F., Tackenberg, B., Lunemann, J. D. Tags: All Immunology, Autoimmune diseases, Chronic inflammatory demyelinating polyneuropathy Article Source Type: research